Olanzapine Versus Active Comparator in the Treatment of Bipolar I Disorder
NCT ID: NCT00034580
Last Updated: 2006-07-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
326 participants
INTERVENTIONAL
2001-08-31
2002-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
olanzapine
risperidone
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Female subjects of childbearing potential must be using a medically accepted means of contraception
* Each subject must have a level of understanding sufficient to perform all tests and examinations required by the protocol
* Subjects must be considered reliable
Exclusion:
* Female subjects who are either pregnant or nursing
* Uncorrected hypothyroidism or hyperthyroidism
* Narrow-angle glaucoma
* Subjects who present a serious and immediate risk of endangering him or herself
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Eli Lilly and Company
INDUSTRY
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Berkley, California, United States
Los Angeles, California, United States
Orange, California, United States
San Marcos, California, United States
Torrance, California, United States
Denver, Colorado, United States
Middleton, Connecticut, United States
Washington D.C., District of Columbia, United States
Winter Park, Florida, United States
Boise, Idaho, United States
Hoffman Estates, Illinois, United States
Natick, Massachusetts, United States
St Louis, Missouri, United States
Las Vegas, Nevada, United States
Clementon, New Jersey, United States
Olean, New York, United States
Philadelphia, Pennsylvania, United States
Madison, Tennessee, United States
Houston, Texas, United States
Richmond, Virginia, United States
Roanoke, Virginia, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
F1D-US-HGJT
Identifier Type: -
Identifier Source: secondary_id
5528
Identifier Type: -
Identifier Source: org_study_id